13F

Stock

Acumen Pharmaceuticals, Inc.

ABOS · held by 2 managers

Reported value

$47.6K

Holders

2

+1 new · −0 exited

Holders’ est. mark

$1.8K

Price effect on 1 books still in the name

Largest holder

$34.8K

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC30K$34.8K$1.8KCut−$44.7K
Savant Capital, LLC11K$12.8KNew

Positions as of Q2 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.